Renaud Maloberti joined Samsung Neurologica in January 2023 as the mCT business chief executive and vice president. Renaud is a seasoned global leader with a proven track record in delivering business value and an extensive knowledge of the medical device industry, who values innovation, entrepreneurship, team work, operational excellence and first and foremost customer centricity.
Most recently, Renaud was Chief Commercial Officer at ENDRA Life Sciences a company leading the development of thermoacoustic imaging. Prior to Endra he was leading operations at Bionik Laboratories, a company in the AI enhanced rehabilitation robotics market. From 2012 to 2018, Renaud held various senior executive positions at FujiFilm SonoSite Inc., most recently as vice president and general manager of the SonoSite High Frequency division, where he led the development and launch of the world's first ultra-high frequency ultrasound and led the division through double-digit revenue growth for six years.
Renaud previously served as President, Americas for BK Medical Systems, the ultrasound subsidiary of Analogic Corporation. Earlier in his career, Maloberti worked at Draeger Medical Systems, a leader in patient monitoring and healthcare IT systems. Maloberti also spent 10 years in various progressive roles in Europe and the US at GE Healthcare, a global leader in diagnostic imaging, healthcare IT systems and services.
Renaud holds an M.B.A. in global marketing from Babson College and a bachelor’s degree in International Finance from ESLSCA Business School in Paris, France. He is fluent in English and French.
Dr. Bechwati earned his Ph.D. and M.S. in E.E. from Boston University, and his Diploma of Engineering from Saint Joseph University, Beirut, Lebanon. While a doctoral student, he received the GRS-ENG Research Assistant Scholarship award for research in Continuous Speech Recognition which was sponsored by DARPA. Dr. Bechwati worked for two winners of the National Medal of Technology: Bernard Gordon, the father of high speed analog-to-digital conversion and the futurist Ray Kurzweil. At Kurzweil AI, he worked on the first voice activated word processor. In his eight years tenure at Analogic Corporation, Dr. Bechwati participated in the development of several pioneer scanners including the first multislice explosive detection scanner as a part of the government deterrent initiative, and the first low cost multislice scanner equipped with off-the-shelf PC based reconstruction computer. He also worked on one of the first sub-second scanners as well as low cost security scanners for carry-on luggage. As a founding member of Neurologica, Dr. Bechwati worked on the CereTom, the first mobile head and neck scanner, and on the development of the BodyTom, the first mobile full body scanner. Dr. Bechwati has more than 20 patents and more than 100 technical reports. Dr. Bechwati has published in academic journals such as IEEE Transactions on Signal Processing, and Neurology. He recently co-authored a chapter for the Neurophotonics and Brain Mapping book published by the Taylor and Francis Group.
Mr. Limoli began his career with NeuroLogica in 2004 as the Principal Software engineer. He was vital in the release of NeuroLogica’s first product, the CereTom, a portable small bore CT scanner. Limoli was the Product Engineer for Neurologica’s full body BodyTom launched in 2011 and has served as the Vice President of Engineering since 2013. Under his leadership, developed NeuroLogica‘s latest product, the OmniTom, the portable, omnidirectional multi-slice CT scanner. Prior to his work with NeuroLogica, Limoli spent ten years with Analogic as a software and project engineer and was instrumental in the development of a number of medical and security computed tomography systems. Limoli received his Bachelor of Science in Computer Science from Salem State University and holds a Master’s of Science in Organizational Leadership from Norwich University.
Ninad Gujar joined NeuroLogica in 2014, leading the Regulatory and Quality team. Dr. Gujar has held key leadership positions in organizations working at the intersection of technology and healthcare with responsibility for activities supporting product adoption and value creation. Dr. Gujar has led the development and execution of worldwide regulatory strategy, domestic and international registrations, implementation and monitoring of quality management system and compliance activities. Prior to joining Samsung, Dr. Gujar worked in management consulting for portfolio medical device companies in areas ranging from market research, product strategy, business development and regulatory affairs. Dr. Gujar is an active member of the healthcare innovation and entrepreneurship community, helping mentor startups at incubators and universities.
Dr. Gujar earned a Bachelor of Engineering from University of Pune, a Master of Science in Biomedical Engineering from University of Texas at Arlington, a MBA from Babson College and received his Ph.D. degree from University of West London.
Mr. Koshnitsky joined Neurologica in 2019. He is a seasoned, entrepreneurial Healthcare Executive with 30 years experience both in the US and Internationally. He has held multiple leadership roles, with large multinational companies as well as small and medium start-up companies, including CEO, General Manager, and various global Director and VP roles with expertise in the medical device and software industries. Mr. Koshnitsky started his career as a Medical Physicist prior to MBA transitioning to corporate leadership. He earned a Bachelor of Science degree from State University of New York Empire State, and a Master's of Business Administration degree from SDA Bocconi.